BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6302196)

  • 1. [Serum and tissue 17 beta hydroxysteroid dehydrogenase and estrogens in hydatidiform mole].
    Massart C; Le Pogamp C; Nicol M
    J Clin Chem Clin Biochem; 1983 Feb; 21(2):77-82. PubMed ID: 6302196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11beta-Hydroxysteroid dehydrogenase activity in pregnancies complicated by hydatidiform mole.
    Muneyyrici-Delale O; Nacharaju VL; Sidell J; Neil G; Karacan M; Camilien L; Temkin S; Abulafia O
    Am J Reprod Immunol; 2006 Jun; 55(6):415-9. PubMed ID: 16674598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma hormone concentrations and serum 17 beta-hydroxysteroid dehydrogenase activity in molar pregnancy.
    Massart C; Le Pogamp C; Nicol M
    Clin Chem; 1982 Jul; 28(7):1474-7. PubMed ID: 6952965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Glucuronidase and oestrogens in hydatidiform mole.
    Leung KC; Lee YT; Fung KP; Yu WN; Yu CC
    Clin Chim Acta; 1976 Nov; 72(3):295-300. PubMed ID: 10109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of estrogens in women with hydatidiform mole and choriocarcinoma.
    Brinck-Johnsen T; Solc J; Galton VA
    Obstet Gynecol; 1970 Nov; 36(5):671-4. PubMed ID: 5473994
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the activity of 17 beta-hydroxysteroid dehydrogenase in human adipose tissue.
    Folkerd EJ; James VH
    J Steroid Biochem; 1982 Apr; 16(4):539-43. PubMed ID: 6953289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue.
    Bonney RC; Reed MJ; Davidson K; Beranek PA; James VH
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):727-39. PubMed ID: 6317235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.
    Gangloff A; Garneau A; Huang YW; Yang F; Lin SX
    Biochem J; 2001 May; 356(Pt 1):269-76. PubMed ID: 11336660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prediction of malignant transformation of hydatidiform mole by mRNA determination of matrix metalloproteinases and tissue inhibitor of metalloproteinases].
    Li Z; Xiang Y; Dai L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Sep; 35(9):547-50. PubMed ID: 11775947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homocysteine, vitamin B12 and folate levels in hydatidiform moles and histopathological subtypes.
    Kokanali MK; Oztürkkan D; Unsal N; Möroy P; Güngör T; Mollamahmutoğlu L
    Arch Gynecol Obstet; 2008 Dec; 278(6):531-4. PubMed ID: 18379803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ethanol and other organic solvents on the kinetic behaviour of purified human placental oestradiol-17 beta-dehydrogenase.
    Lübbert H
    Acta Endocrinol (Copenh); 1982 Mar; 99(3):448-53. PubMed ID: 6951385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization and assay of a 17beta-hydroxysteroid dehydrogenase in the serum of pregnant women.
    Lübbert H
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):642-52. PubMed ID: 14469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The source of estradiol-17beta in trophoblastic neoplasia.
    Dawood MY
    Am J Obstet Gynecol; 1975 Oct; 123(3):286-90. PubMed ID: 1180292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterization and kinetics of a microsomal 17-beta-hydroxysteroid oxidoreductase from human placenta].
    Lehmann WD; Breuer H
    Hoppe Seylers Z Physiol Chem; 1967 Dec; 348(12):1633-9. PubMed ID: 4385014
    [No Abstract]   [Full Text] [Related]  

  • 15. Nicotinamide adenine dinucleotide-dependent 15-hydroxyprostaglandin dehydrogenase activity in hydatidiform mole tissue and choriocarcinoma cells.
    Casey ML; Gal D; Johnston JM; MacDonald PC
    Cancer Res; 1981 Jul; 41(7):2581-2. PubMed ID: 7248931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of human placental aromatase in abnormal pregnancy--anencephalus and hydatidiform mole.
    Yamamoto T; Inoue S; Kitawaki J; Honjo H
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):219-21. PubMed ID: 9365193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on 17 beta-hydroxysteroid dehydrogenase in human endometrium and endometrial carcinoma. III. Partial purification and characterization of the microsomal enzyme.
    Pollow K; Lübbert H; Pollow B
    Acta Endocrinol (Copenh); 1975 Oct; 80(2):355-64. PubMed ID: 241186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
    Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
    BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of 17-beta estradiol dehydrogenase in pregnancies complicated by hydatidiform mole and in twin pregnancies].
    Plotti G; Montemurro A; Primicerio M; Moneta E; Bompiani A
    Ann Ostet Ginecol Med Perinat; 1976; 97(2):76-82. PubMed ID: 949148
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetic studies of oestradiol 17 beta-hydroxysteroid dehydrogenase in MCF-7 mammary cancer cells.
    Bonney RC; Reed MJ; James VH
    J Steroid Biochem; 1985 Dec; 23(6A):1079-81. PubMed ID: 3867810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.